Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice

Inflammatory Bowel Diseases

Volumn 15, Issue 12, 2009, Pages 1824-1836

  De Buhr, Maike F ^a   Hedrich, Hans J ^a   Westendorf, Astrid M ^b,c   Obermeier, Florian ^d   Hofmann, Claudia ^d   Zschemisch, Nils H ^a   Buer, Jan ^b,c   Bumann, Dirk ^e   Goyert, Sanna M ^f   Bleich, Andre ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e UNIVERSITY OF BASEL   (Switzerland)

^f CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Animal models of IBD; Cytokine deficiency induced colitis susceptibility; Genetic susceptibility; Inflammation in IBD; Innate immune system; Pathology; Quantitative trait locus analysis; Toll like receptors

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; LUCIFERASE; PROSTAGLANDIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENETIC POLYMORPHISM; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; ANTIGENS, CD14; BASE SEQUENCE; CELL LINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDOGLYCAN; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI;

EID: 72549110487     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21030     Document Type: Article

References (56)

1. Klein W. Tromm A. Griga T. Fricke H. Folwaczny C. Hocke M. Eitner K. Marx M. Duerig N. Epplen J.T. A polymorphism in the CD14 gene is associated with crohn disease Scandinavian Journal of Gastroenterology 2002 37 2 189-191 DOI 10.1080/003655202753416867 1. Klein W, Tromm A, Griga T, et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol. 2002;37:189-191. (Pubitemid 34102256)
2. Gazouli M. Mantzaris G. Kotsinas A. Zacharatos P. Papalambros E. Archimandritis A. Ikonomopoulos J. Gorgoulis V.G. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population World Journal of Gastroenterology 2005 11 5 681-685 2. Gazouli M, Mantzaris G, Kotsinas A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 2005;11:681-685. (Pubitemid 40220757)
3. Baumgart D.C. Buning C. Geerdts L. Schmidt H.H. Genschel J. Fiedler T. Gentz E. Molnar T. Nagy F. Lonovics J. Lochs H. Wiedenmann B. Nickel R. Witt H. Dignass A. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease Digestion 2007 76 3 4 196-202 DOI 10.1159/000112646 3. Baumgart DC, Buning C, Geerdts L, et al. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion. 2007;76:196-202. (Pubitemid 351351673)
4. Obana N. Takahashi S. Kinouchi Y. Negoro K. Takagi S. Hiwatashi N. Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14 Scandinavian Journal of Gastroenterology 2002 37 6 699-704 DOI 10.1080/00365520212504 4. Obana N, Takahashi S, Kinouchi Y, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol. 2002;37:699-704. (Pubitemid 34620933)
5. Wang F. Tahara T. Arisawa T. Shibata T. Nakamura M. Fujita H. Iwata M. Kamiya Y. Nagasaka M. Takahama K. Watanabe M. Hirata I. Nakano H. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis Journal of Gastroenterology and Hepatology 2007 22 6 925-929 DOI 10.1111/j.1440-1746.2007.04909.x 5. Wang F, Tahara T, Arisawa T, et al. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol. 2007;22:925-929. (Pubitemid 46911033)
6. Klein W. Tromm A. Griga T. Folwaczny C. Hocke M. Eitner K. Marx M. Duerig N. Epplen J.T. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease Scandinavian Journal of Gastroenterology 2003 38 8 834-836 DOI 10.1080/00365520310003147 6. Klein W, Tromm A, Griga T, et al. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol. 2003;38:834-836. (Pubitemid 37011576)
7. Peters KE, O'Callaghan NJ, Cavanaugh JA. Lack of association of the CD14 promoter polymorphism - 159C/T with Caucasian inflammatory bowel disease. Scand J Gastroenterol. 2005;40:194-197.
8. Torok HP, Glas J, Tonenchi L, et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol. 2004;112:85-91. (Pubitemid 38781061)
9. Canto E, Ricart E, Monfort D, et al. TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol. 2006;119:156-165.
10. Baldini M, Lohman IC, Halonen M, et al. A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20:976-983. (Pubitemid 129540855)
11. Griga T, Klein W, Epplen JT, et al. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. Hepatogastroenterology. 2005;52:808-811. (Pubitemid 40834609)
12. Farmer MA, Sundberg JP, Bristol IJ, et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A. 2001;98:13820-13825. (Pubitemid 33115982)
13. Mähler M, Most C, Schmidtke S, et al. Genetics of colitis susceptibility in IL-10-deficient mice: backcross versus F2 results contrasted by principal component analysis. Genomics. 2002;80:274-282. (Pubitemid 34985017)
14. de Buhr MF, Mähler M, Geffers R, et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics. 2006;25:426-434.
15. Bleich A, Mähler M, Most C, et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. 2004;15:865-871. (Pubitemid 40064197)
16. Gupta D, Kirkland TN, Viriyakosol S, et al. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem. 1996;271:23310-23316. (Pubitemid 26314774)
17. Pugin J, Schurer-Maly CC, Leturcq D, et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide- binding protein and soluble CD14. Proc Natl Acad Sci U S A. 1993;90:2744-2748. (Pubitemid 23113493)
18. Kitchens RL, Thompson PA, Viriyakosol S, et al. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest. 2001;108:485-493. (Pubitemid 32730795)
19. Jacque B, Stephan K, Smirnova I, et al. Mice expressing high levels of soluble CD14 retain LPS in the circulation and are resistant to LPS-induced lethality. Eur J Immunol. 2006;36:3007-3016. (Pubitemid 44782574)
20. Lee JW, Paape MJ, Elsasser TH, et al. Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infect Immun. 2003;71:4034-4039. (Pubitemid 36753730)
21. Ortega-Cava CF, Ishihara S, Rumi MA, et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol. 2003;170:3977-3985. (Pubitemid 36428158)
22. Rogler G, Hausmann M, Vogl D, et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol. 1998;112:205-215. (Pubitemid 28266678)
23. Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36:20-42. (Pubitemid 34073119)
24. Liedtke C, Groger N, Manns MP, et al. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J Biol Chem. 2003;278:27593-27604. (Pubitemid 36899945)
25. Obermeier F, Strauch UG, Dunger N, et al. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut. 2005;54:1428-1436.
26. Cartharius K, Frech K, Grote K, et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005;21:2933-2942. (Pubitemid 40916416)
27. Funda DP, Tuckova L, Farre MA, et al. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun. 2001;69:3772-3781. (Pubitemid 32493296)
28. Rogler G, Andus T, Aschenbrenner E, et al. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:893-899. (Pubitemid 27404418)
29. Arnott ID, Nimmo ER, Drummond HE, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?Genes Immun. 2004;5:417-425.
30. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001;167:5838-5844.
31. Schreiber S, Rosenstiel P, Hampe J, et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut. 2002;51:379-385. (Pubitemid 34907706)
32. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology. 2003;124:1265-1276. (Pubitemid 36531802)
33. Takeda N, Arima M, Tsuruoka N, et al. Bcl6 is a transcriptional repressor for the IL-18 gene. J Immunol. 2003;171:426-431. (Pubitemid 36745316)
34. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557-561. (Pubitemid 46514732)
35. Obermeier F, Dunger N, Strauch UG, et al. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology. 2005;129:913-927. (Pubitemid 41242684)
36. Bleich A, Janus LM, Smoczek A, et al. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology. 2009;136:278-287.
37. Kitajima S, Morimoto M, Sagara E, et al. Dextran sodium sulfate - induced colitis in germ-free IQI/Jic mice. Exp Anim. 2001;50:387-395. (Pubitemid 33692774)
38. Greweling MC, Rozell B, Bleich A, et al. Commensal gut flora reduces susceptibility to DSS colitis most likely via T-cell derived interleukin-10 [Abstract]. Wien Klin Wochenschr. 2008;120(Suppl 1):360-368.
39. Hans W, Schölmerich J, Gross V, et al. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000;12:267-273. (Pubitemid 30168579)
40. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007;132:1359-1374. (Pubitemid 46627595)
41. Fukata M, Michelsen KS, Eri R, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1055-G1065.
42. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology. 2006;131:862-877. (Pubitemid 44316821)
43. Fine S, Gonzalez Navajas J, Shen C, et al. The protective role of TLR4 signaling in IL-10 dependent colitis. Gastroenterology. 2007;132:A124.
44. Lee J, Mo JH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006;8:1327-1336. (Pubitemid 44835107)
45. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-241. (Pubitemid 38962578)
46. Fukata M, Breglio K, Chen A, et al. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol. 2008;180:1886-1894.
47. Liu G, Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology. 2007;122:149-156. (Pubitemid 47389958)
48. Bleich A, Janus LM, Smoczek A, et al. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology. 2008.
49. Branger J, Knapp S, Weijer S, et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004;72:788-794. (Pubitemid 38166657)
50. Bleich A, Kirsch P, Sahly H, et al. Klebsiella oxytoca: opportunistic infections in laboratory rodents. Lab Anim. 2008;42:369-375. (Pubitemid 352029866)
51. Bleich A, Sundberg JP, Smoczek A, et al. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. Int J Exp Pathol. 2008;89:45-54.
52. Wenneras C, Ave P, Huerre M, et al. Blockade of CD14 aggravates experimental shigellosis. J Endotoxin Res. 2001;7:442-446. (Pubitemid 34048528)
53. Bleich A, Mähler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis. Pathobiology. 2005;72:293-307.
54. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002;123:1527-1542. (Pubitemid 35231653)
55. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694-702. (Pubitemid 20069706)
56. Kühn R, Löhler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274. (Pubitemid 23320290)